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The liver plays a central role in whole-body lipid
and glucose homeostasis. Increasing dietary fat
intake results in increased hepatic fat deposition,
which is associated with a risk for development
of insulin resistance and type 2 diabetes. In this
study, we demonstrate a role for the phosphate inor-
ganic transporter 1 (PiT1/SLC20A1) in regulating
metabolism. Specific knockout of Pit1 in hepato-
cytes significantly improved glucose tolerance and
insulin sensitivity, enhanced insulin signaling, and
decreased hepatic lipogenesis. We identified USP7
as a PiT1 binding partner and demonstrated that
Pit1 deletion inhibited USP7/IRS1 dissociation upon
insulin stimulation. This prevented IRS1 ubiquitina-
tion and its subsequent proteasomal degradation.
As a consequence, delayed insulin negative feed-
back loop and sustained insulin signaling were
observed. Moreover, PiT1-deficient mice were pro-
tected against high-fat-diet-induced obesity and dia-
betes. Our findings indicate that PiT1 has potential as
a therapeutic target in the context of metabolic syn-
drome, obesity, and diabetes.
INTRODUCTION
Obesity has rapidly become a worldwide epidemic disease and
results in increased risk of cardiovascular disease, type 2 dia-
betes mellitus, and metabolic syndrome (Ma˚rtensson et al.,
2009). Metabolic syndrome is characterized by increased
visceral adiposity, hyperlipidemia, insulin resistance, and hyper-
tension (Alberti et al., 2006). The liver maintains glucose and lipid
homeostasis. Hepatic steatosis, characterized by massive fat
accumulation in the liver, correlates with features of metabolic
syndrome, including hyperlipidemia and insulin resistance2736 Cell Reports 16, 2736–2748, September 6, 2016 ª 2016 The Au
This is an open access article under the CC BY-NC-ND license (http://(Home and Pacini, 2008). Indeed, loss of insulin action in the liver
leads to abnormally high hepatic gluconeogenesis, glucose pro-
duction, and lipogenesis, as well as decreased insulin clearance,
hepatic glucose uptake, and lipolysis, consequently resulting in
dyslipidemia (Perry et al., 2014).
The insulin pathway mediates glucose uptake in muscles
(Khan and Pessin, 2002), lipogenesis (Girard et al., 1994),
glycogen storage (Cross et al., 1995), and gluconeogenesis sup-
pression in the liver (Cherrington, 1999). The binding of insulin to
the insulin receptor (IR) promotes its autophosphorylation (Zick
et al., 1983) and subsequent phosphorylation of downstream
targets, such as IR substrate (IRS) proteins, which mediate the
biological action of insulin (Sun et al., 1991). Tyrosine phosphor-
ylation of IRS1 by IR generates binding sites for the p85 subunit
of phosphatidylinositol 3-kinase (PI3K), leading to recruitment of
AKT and its activation via Thr308 phosphorylation (Franke et al.,
1997).
Insulin signaling is tightly regulated by inhibitor proteins and
negative feedback loops. Phosphatase and TENsin homolog
(PTEN) is a plasma membrane lipid phosphatase that dephos-
phorylates phosphatidylinositol (3,4,5)-trisphosphate (PIP3) to
produce the diphosphate PIP2, thereby inhibiting the phos-
phorylation of AKT (Stambolic et al., 1998). PTEN is also a pro-
tein tyrosine phosphatase of IRS1 (Shi et al., 2014). IRS1 is a
major adaptor protein in insulin signaling. Its ubiquitination
and degradation are part of a negative feedback loop that
attenuates insulin signaling (Rice et al., 1993; Ricort et al.,
1995). Phosphorylations on serines and threonines of IRS1
are required for its ubiquitination and degradation (Xu et al.,
2012), and insulin-mediated IRS1 hyperphosphorylation is
mainly due to mTOR/S6K pathway activation (Haruta et al.,
2000).
PiT1 (SLC20A1) and PiT2 (SCL20A2), initially identified as
retrovirus receptors (Miller and Miller, 1994; O’Hara et al.,
1990), are plasma membrane proteins belonging to the
SLC20A family of mammalian sodium-dependent inorganic
phosphate (Pi) transporters (Collins et al., 2004; Kavanaugh
et al., 1994). The broad tissue distribution of PiT1 and PiT2thor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Phenotype of TG Mice
(A) qPCR analysis of Pit1 expression in livers of WT
and TG mice sacrificed at 6 months of age. Data
are means ± SEM; n = 3 per condition. Significant
difference fromWTmice is indicated (***p < 0.001).
(B–H) WT (black bars) and TG (white bars) mice
were fed a chow diet. Data are means ± SEM of at
least eight animals per condition. Significant dif-
ferences from WT mice are indicated (*p < 0.05;
**p < 0.01; ***p < 0.001). (B) Body weights at
5 weeks of age are shown. (C) Body weights at
6 months of age are shown. (D) Epididymal white
adipose tissue weights at 6 months of age are
shown. (E) Food intake is shown. (F) RERs in light
and dark periods are shown. (G) Energy expendi-
tures in light and dark periods normalized as
described in material and methods section are
shown. (H) Fasted glycemia levels at 6 months of
age are shown.first led to the assumption that they played an unregulated
house-keeping role in supplying Pi to cells (Kavanaugh et al.,
1994; Uckert et al., 1998); however, significant differences
in expression levels and ratios among tissues suggest that
these two transporters have specific and non-redundant roles
in vivo. Recently, functions of PiT1 that are independent of
its role in phosphate transport have been identified. PiT1 is
involved in regulation of proliferation, density, and adhesion
(Beck et al., 2009; Byskov et al., 2012; Kongsfelt et al., 2014),
embryonic mouse liver development (Beck et al., 2010), tumor
necrosis factor (TNF)-induced apoptosis (Sala€un et al., 2010),
and erythroid and B cell differentiation (Forand et al., 2013; Liu
et al., 2013). How PiT1 drives these different functions is
currently unknown.
In the present study, we describe a function of PiT1 in glucose
metabolism. Hepatocyte-specific knockout (KO) of Pit1 pro-
tected mice from obesity and diabetes normally induced by
high-fat and high-carbohydrate diets. Mice KO for Pit1 in
hepatocytes displayed improved glucose tolerance, insulin
sensitivity, and enhanced insulin signaling when compared to
wild-type mice. We determined that the prolonged insulin
signaling in these PiT1-deficient mice is caused by a defect in
the negative feedback loop that regulates IRS1 ubiquitination
and degradation, specifically involving the deubiquitinating
enzyme ubiquitin-specific peptidase 7 (UPS7), which is a binding
partner of PiT1.Cell ReportRESULTS
Specific Hepatocyte Pit1-KO
Protects against Weight Gain
Induced by Aging
We previously generated Pit1-KO mice
and found that disruption of Pit1 expres-
sion leads to mid-gestation lethality due
to reduced proliferation and massive
apoptosis of liver cells (Beck et al.,
2010). In order to determine whether
PiT1 is required for hepatic functions atthe adult stage, we crossed Pit1-floxed mice with albumin-Cre
(Alb-Cre) mice to deletePit1 only in hepatocytes (see the Supple-
mental Experimental Procedures). Pit1 expression was analyzed
in livers of Alb-Cre; Pit1lox/loxmice (here referred as to transgenic
[TG] mice) and Alb-Cre; Pit1WT/WT mice (here referred as to wild-
type [WT]) littermates. In TG mice, Pit1mRNA levels were 5% of
levels in WT, probably due to Pit1 expression in non-hepatocyte
cell types (Figure 1A).
Body weight and metabolic parameters of TG mice were
analyzed beginning at 5 weeks of age for 4 months (Figures 1B
and 1C; Table 1). Body weights were similar at the beginning
of the experiment (Figure 1B), but TG mice were lighter than
WT mice at 6 months of age (Figure 1C). Moreover, TG mice
had less epididymal white adipose tissue (WAT) weight (Fig-
ure 1D). Cholesterol and high-density lipoprotein (HDL) levels
were lower in TG mice, whereas triglycerides and non-esterified
fatty acid and glycerol levels did not differ from levels in WTmice
(Table 1). Interestingly, TG mice and WT mice had similar levels
of glycemia, although the TG mice had lower insulin concentra-
tions at the fed stage (Table 1). These results show that lack of
PiT1 in hepatocytes protects against age-induced weight gain
and suggests that PiT1 could be involved in regulation of glucose
and lipid metabolism.
Body weight represents a net balance of food intake and en-
ergy expenditure. Our analysis showed that food intake of WT
and TG mice was similar (Figure 1E). Respiratory exchange ratios 16, 2736–2748, September 6, 2016 2737
Table 1. Metabolic Parameters of WT and TG Mice
Pit1-WT Chow Pit1-KO Chow Pit1-WT HFD Pit1-KO HFD
Glucose (mmol/l) 18.58 ±1.53 17.47 ±1.08 29.42$$$ ±1.72 20.81** ±1.62
Insulin (pg/ml) 1,621.35 ±308.60 741.35* ±101.08 2,603.87 ±459.85 2,184.56$ ±567.18
Glucagon (pg/ml) 130.80 ±15.20 41.74*** ±7.44 nd nd nd nd
TG (mmol/l) 0.89 ±0.06 0.83 ±0.07 0.72 ±0.06 0.82 ±0.06
NEFA (mmol/l) 0.60 ±0.06 0.57 ±0.08 1.40$$ ±0.18 1.34$$$ ±0.11
Glycerol (mmol/l) 223.23 ±11.46 180.61 ±22.30 324.54$$ ±26.35 339.88$$$ ±30.38
b-OH (mmol/l) 0.07 ±0.01 0.04* ±0.01 0.31$ ±0.08 0.13*,$ ±0.04
Cholesterol (mmol/l) 3.05 ±0.21 2.30** ±0.10 6.68$$$ ±0.37 5.09*,$$ ±0.48
HDL (mmol/l) 2.17 ±0.11 1.71** ±0.08 4.54 ±0.34 3.52*,$$$ ±0.26
Serum samples were collected from 6-month-old male mice fed ad libitum. Data are presented asmeans ± SEMof at least eight animals per condition.
Significant differences from WT mice (*p < 0.05; **p < 0.01; ***p < 0.001) and mice fed chow ($p < 0.05; $$p < 0.01; $$$p < 0.001) are indicated.(RER) is an indicator of the substrate metabolized to supply en-
ergy (with an RER of 1 indicative of carbohydrate; 0.7 of lipids).
TG mice had higher RER during fasting (light period) than did
WT mice, suggestive of higher carbohydrates consumption (Fig-
ure 1F), but energy expenditures were similar (Figure 1G). The
higher carbohydrate consumption by TG mice correlated with
lower fasting hypoglycemia relative to WT mice (Figure 1H).
These results show that protection against weight gain was not
completely explained by differences in food intake or energy
expenditure. Nevertheless, increased carbohydrates consump-
tion during the resting period and subsequent hypoglycemia
may be involved in the phenotype of the TG mice.
Hepatocyte-Specific Pit1-KO Does Not Impair
Gluconeogenesis
The liver controls glucose homeostasis. During feeding, glucose
is converted to glycogen for storage, whereas in fasting periods,
the liver produces glucose by gluconeogenesis. Because our TG
mice had lower fasting glycemia thanWTmice, we hypothesized
that the TGmicemight have a defect in gluconeogenic enzymes.
Levels of mRNAs encoding a number of enzymes involved in
gluconeogenesis were evaluated in livers of fasted mice (Fig-
ure 2A). TG livers had higher levels of Pgc1a, which encodes a
transcription factor involved in gluconeogenic gene expression,
and of Pck1, which encodes an enzyme critical to gluconeogen-
esis. Phosphoenolpyruvate carboxykinase (PEPCK) protein
levels were higher in TG mice, but pyruvate dehydrogenase 4
(PDK4) levels did not differ from those in WT mice (Figure 2B).
These results suggest that low fasting glycemia in TG mice
does not result from impaired gluconeogenesis and that PEPCK
level increases in TG mice in response to the fasting hypoglyce-
mia observed during the light period (Figure 1F), but not as a
direct consequence of Pit1 hepatocyte KO.
In order to evaluate intrinsic hepatic glucose production, Pck1
expression was analyzed in vitro in primary hepatocytes taken
from TG and WT mice in basal (low glucose) and stimulated
(high glucose plus insulin) conditions. No significant differences
were observed. Pck1 expression was decreased in stimulated
conditions for both KO and WT cells (Figure S1A), and glucose
production from pyruvate did not differ (Figure S1B). Thus, Pit1-
KO inhepatocytesdoesnot intrinsicallymodify gluconeogenesis.2738 Cell Reports 16, 2736–2748, September 6, 2016Hepatocyte-Specific Pit1-KO Improves Glucose
Tolerance and Insulin Sensitivity in Chow-Fed Mice
TG mice had similar fed glucose levels but lower insulin levels
than WT mice (Table 1). In intraperitoneal glucose and insulin
tolerance tests, TGmice had higher glucose tolerance and lower
insulin levels (Figure 2C) and were slightly more sensitive to insu-
lin (Figure 2D) than WT mice in accordance with other results
showing that TG mice are more sensitive to insulin. Tolerance
to pyruvate injection was similar (Figure 2E) in accordance with
the analysis of primary hepatocytes (Figure S1B).
To investigate how disruption of Pit1 in hepatocytes sensi-
tized mice to insulin, we evaluated insulin signaling in the liver.
Insulin injection induced a much-stronger phosphorylation of
IR in TG mice than in WT (Figure 2F). IR protein and mRNA
levels were also higher in TG livers (Figures 2F and S2). Subse-
quent phosphorylations of AKT on Thr308 (by PI3K/PDK1) and
Ser473 (by mTOR) were also stronger in TG mice. AKT is
known to phosphorylate GSK-3 to enhance glycogenesis.
Higher levels of GSK-3 phosphorylation were observed in TG
livers, and this correlated with higher levels of glycogen storage
in TG compared to WT livers as shown by the periodic acid
Schiff (PAS) staining (Figure 2G). These results show that
Pit1-KO hepatocytes have improved insulin signaling compared
to WT.
Improved Insulin Signaling in Pit1-KOMEFs Comes from
Increased IR Levels andProlongedAKTPhosphorylation
We next investigated the insulin-signaling pathway in WT and
Pit1-KO mouse embryonic fibroblasts (MEFs). We observed
stronger IR phosphorylation in KO MEFs than in WT cells (Fig-
ure 3A). Insulin pathway kinetics also differed. A decrease in
AKT phosphorylation kinetics paralleled IRS1 degradation in
WT MEFs, whereas AKT phosphorylation on both Ser473 and
Thr308 was prolonged in KO MEFs (Figures 3A and S3A). Sur-
prisingly, IRS1 was more stable and less hyperphosphorylated
in KO MEFs, based on the electrophoretic mobility shift (Haruta
et al., 2000; Figure 3A). Interestingly, when MG132, a protea-
some inhibitor, was added to the cell culture, WT MEFs showed
the same prolonged AKT phosphorylation as did KO cells (Fig-
ure 3B). These results suggest that improved insulin signaling
observed in KO MEFs comes from increased IR levels and
Figure 2. Pit1 Hepatocyte KO Improves
Glucose Tolerance and Insulin Sensitivity
In Vivo
(A) qPCR analysis of the gluconeogenic genes
Pgc1a, Hnf4, Foxo1, G6pase, and Pck1 in livers of
chow-fedWT (black bars) and TG (white bars) mice
fasted overnight.
(B) Representative western blot of liver proteins
from fasted WT and TG mice.
(C) Chow-fed mice were fasted overnight and then
injected intraperitoneally with 2 g/kg body weight
D-glucose. Blood glucose (upper panel) and serum
insulin (lower panel) were monitored in WT (solid
line, n = 6) and TG (dotted line, n = 8) mice.
(D) Chow-fed mice were fasted overnight and then
injected intraperitoneally with 1 U/kg body weight
human insulin. Blood glucose was measured in WT
(solid line, n = 8) and TG (dotted line, n = 8) mice.
Upper panel represents raw data; lower panel
expresses glycemia as percentage of basal con-
centration.
(E) Chow-fed mice were fasted overnight and then
injected intraperitoneally with 2 g/kg body weight
pyruvate. Blood glucose was measured in WT
(solid line, n = 8) and TG (dotted line, n = 8) mice.
For (C)–(E), data are means ± SEM. Significant
differences from WT mice are indicated (*p < 0.05;
**p < 0.01; ***p < 0.001).
(F) Representative western blot of liver proteins
from WT and TG mice after 5-min insulin pulse.
Image on the left shows total protein, and that on
the right shows phosphorylated form. GAPDH was
used as a loading control.
(G) Representative images of liver sections from
WT (left) and TG (right) mice stained with PAS. The
scale bar represents 1 mm.prolonged AKT phosphorylation that is due, at least in part, to a
defect in proteasomal degradation of one or more proteins
involved in insulin signaling.
IRS1 is an important mediator of IR signaling and phosphory-
lation on serine, and threonine residues are required for its
ubiquitination and degradation (Xu et al., 2012). We therefore
investigated phosphorylation on Ser632 and Ser302 in the KO
and WT MEFs. Robust phosphorylation was observed 1 hr after
insulin stimulation in WT MEFs, but not in KO MEFs (Figure 3C).
Surprisingly, we found similar activation of the mTOR/S6K
pathway as evaluated by S6 (Figure 3C), S6K, and 4EBP1 phos-
phorylation (data not shown). IRS1 Ser1097 phosphorylation,
which is dependent on both S6K and PKCq (Li et al., 2004b),
was also impaired in KO MEFs. From these results, we
concluded that the impairment of IRS1 degradation in KO
MEFs was likely the consequence of low levels of phosphoryla-Cell Reportion on serine and threonine. We next
evaluated IRS1 ubiquitination. A strong
polyubiquitination of IRS1 was observed
in WT MEFs 3 and 6 hr after insulin stimu-
lation, whereas ubiquitination was signifi-
cantly lower in KO MEFs (Figure 3D).
These results suggest that the defect in
IRS1 phosphorylation and ubiquitinationin MEFs that lack PiT1 stabilizes IRS1 and delays the insulin
negative feedback loop.
USP7 Is a PiT1 Binding Partner
We assumed that PiT1 binds to selected protein partners
through its large intracellular domain (Farrell et al., 2009). This
domain (residues 250–510) was therefore used as bait in a
yeast two-hybrid screen, and USP7 was identified as a PiT1
binding partner with high degree of confidence in the interac-
tion. To confirm this interaction, we overexpressed V5-tagged
PiT1 in MEFs. V5-tagged PiT1 co-purified with endogenous
USP7 (Figure 3E). We also overexpressed V5-tagged PiT1 pro-
tein in HepG2 and primary hepatocytes and confirmed that
endogenous USP7 co-purified PiT1-V5 (Figure S3B). These
data indicate that PiT1 and USP7 directly interact in mammalian
cells.ts 16, 2736–2748, September 6, 2016 2739
Figure 3. Insulin Signaling and IRS1 Ubiqui-
tination Are Defective in Pit1-KO MEFs
(A) Representative western blot of overnight
serum-starved and insulin-stimulated WT and
KO MEFs.
(B) Representative western blot of overnight
serum-starved and insulin-stimulated WT and KO
MEFs in presence of proteasome inhibitor MG132.
(C) Representative western blot evaluating IRS1
phosphorylation and mTOR/S6K pathway activa-
tion.
(D) (Upper panel) Representative western blot of
ubiquitin after IRS1 immunoprecipitation in WT
and KOMEFs, serum starved overnight and insulin
stimulated in presence of MG132. (Lower panel)
Total lysate blots are shown.
(E) (Left panel) Representative western blot for
USP7 immunoprecipitated with V5-PiT1 from
serum-starved, insulin-stimulated WT MEFs
treated with MG132. (Right panel) Total lysate blot
is shown.USP7 Does Not Totally Dissociate from IRS1 upon
Insulin Stimulation
USP7 is a deubiquitinating enzyme that interacts with IRS1 to
prevent its ubiquitination and subsequent proteasomal degrada-
tion (Yoshihara et al., 2012). USP7 and IRS1 interacted inWT and
KO MEFs under serum starvation conditions (Figure 4A). USP7
began to dissociate from IRS1 15 min after insulin stimulation
(Figure S4A), but association of USP7-IRS1 remained higher in
KOMEFs at 3 and 6 hr after stimulation compared toWT (Figures
4B and S4B). Immunoprecipitation of endogenous USP7
confirmed this finding (Figures 4C and S4C). Furthermore, the
IRS1/PTEN association (Figures 4A and S4A) and the USP7/
PTEN interaction (Figures 4C and S4C) were lower in KO MEFs
compared to WT. This was parallel to a slight decrease in
PTEN expression in KO MEFs lysates. Taken together, these re-
sults show that PiT1 modulates the USP7/IRS1 and PTEN/IRS1
interactions, impacting IRS1 ubiquitination and degradation.
To confirm the role of PiT1 in insulin signaling and IRS1 ubiq-
uitination, we restored PiT1 expression in KO MEFs. Expression
of PiT1 in the KO MEFs attenuated AKT phosphorylation (Fig-
ure 5A) and restored IRS1 ubiquitination after insulin stimulation
(Figure 5D). We also expressed transport-deficient mutants of
PiT1 in KOMEFs (Figure 5B) in order to determine whether meta-2740 Cell Reports 16, 2736–2748, September 6, 2016bolic effects of PiT1 were dependent on
its phosphate transport function. As for
PiT1 WT rescue, we observed attenuated
AKT phosphorylation in the KOMEFs that
expressed the transport-deficient PiT1
mutant, showing that the effects of Pit1
deletion observed on insulin signaling
are independent of the phosphate trans-
port function of PiT1.
The same experiments were con-
ducted after silencing of USP7 expres-
sion using small interfering RNA (siRNA).
In cells treated with siRNA-targeting
USP7, AKT phosphorylation was attenu-ated (Figure 5C) and IRS1 ubiquitination was enhanced relative
to controls (Figure 5D). Interestingly, in a microarray analysis of
gene expression in the livers of WT and TG mice, ubiquitination
pathway gene expression differed significantly (Figure S5).
Taken together, these results suggest that PiT1 modulates insu-
lin signaling by its interaction with USP7.
Hepatocyte-Specific Pit1-KO Protects against
High-Fat-Diet-Induced Obesity
Quantification of Pit1 expression in liver using real-time PCR re-
vealed that Pit1 was increased in livers of WT mice fed with a
high-fat diet (HFD) and in ob/ob diabetic mice compared with
control mice fed standard chow (Figure S6A). In TG and WT
mice fed HFD and given fructose in drinking water from 5 weeks
of age, body weights were similar at the beginning of the exper-
iment (Figure 1B) but TGmice were lighter (Figure 6A) and leaner
(Figure S6B) after 4 months than WT mice. Weight gain differ-
ences were observed after the 2nd week of HFD (Figure S6C).
Cholesterol and HDL were lower in TG mice than in WT mice
fed the HFD, whereas levels of triglycerides, non-esterified fatty
acids, and glycerol were similar (Table 1). Whereas chow-fed
mice preferentially consumed carbohydrates (RERz 0.9), RER
was decreased for mice fed HFD, traducing high lipids
Figure 4. USP7 Does Not Totally Dissociate
from IRS1 upon Insulin Stimulation in Pit1-
KO MEFs
(A) Representative western blot of USP7 and PTEN
after immunoprecipitation with antibody to IRS1
from WT and KO serum-starved, insulin-stimu-
lated, MG132-treated MEFs for short time points.
The right panel shows blot of total lysate.
(B) Representative western blot of USP7 after
immunoprecipitation with antibody to IRS1 from
WT and KO MEFs serum starved overnight and in-
sulin stimulated in presence ofMG132 for long time
points. The right panel shows blot of total lysate.
(C) Representative western blot of IRS1 and PTEN
immunoprecipitated with antibody to USP7 from
WT and KO serum-starved, insulin-stimulated,
MG132-treated MEFs. The right panel shows blot
of total lysate.consumption whatevermice genotype. TGmice fed the HFD had
slightly higher energy expenditures during the light period than
WT mice (Figure S6E), but no differences in food intake were
observed (Figure S6D). These results show that Pit1 deletion in
hepatocytes protects against HFD-induced obesity.
Hepatocyte-Specific Pit1-KO Protects against Adipose
Tissue Deposition and Inflammation Induced by HFD
In the fed state, under the influence of insulin, WAT stores excess
energy as triacylglycerol. When energy is needed, WAT delivers
fatty acids to be oxidized in peripheral tissues. Increased lipol-
ysis under HFD is a hallmark of adipose tissue insulin resistance.
Surprisingly, non-esterified fatty acids and glycerol were
increased to the same extent in WT and TG mice when fed
HFD compared to chow diet (Table 1). Because HFD is known
to increase adiposity, we determined epididymal WAT mass in
mice fed HFD. TG mice had less epididymal WAT compared to
WT mice (Figure S7A). MRI analyses showed a decrease in
visceral and subcutaneous WAT mass in TG mice (Figures S7B
and S7C) compared to WT mice fed HFD. Adipocytes appeared
slightly smaller in TG mice than in WT mice (Figures S7D and
S7E). Inflammation was evaluated by analysis of expression of
relevant genes: F4/80 mRNA levels were lower in the WAT of
TG mice than WT mice, suggesting that HFD induces less WAT
macrophage infiltration in TGmice. Increases in cytokine-encod-
ing Tnfa and Il6mRNAswere less dramatic in TGmice than inWTCell Reportmice, although differences were not sig-
nificant (Figure S7F). We also observed
that HFD induced an increase in Pit1
expression inWAT (Figure S7F). These re-
sults suggest that Pit1 deletion in hepato-
cytes protects against adipose tissue
deposition and inflammation.
Hepatocyte-Specific Pit1-KO
Protects against Steatosis and
Impaired Liver Function
When released by the adipose tissue,
non-esterified fatty acids are deliveredto the liver. To evaluate liver steatosis, livers were removed
and liver to body weight ratios were determined (Figure 6B).
The ratio in WT mice fed HFD increased by 2.14-fold relative to
that of mice fed standard chow; in contrast, the ratio was only
slightly increased in TG mice (1.27-fold). Thus, HFD significantly
increased liver weight inWTmice, but not in TGmice (Figure 6C).
No difference was observed in livers of WT and TG mice fed a
standard chow diet (data not shown). Histology revealed more
lipid droplets in WT than in TG livers after 4 months on the
HFD (Figure 6D). Finally, triglyceride levels were lower in TG
mice than in WT mice on the HFD (Figure 6E).
Fat accumulation in the liver can occur due to increased fat
delivery, increased fat synthesis, and/or reduced oxidation.
Analyses of mRNAs encoding fatty acid transporter Fabp4 re-
vealed significantly lower levels of expression in livers of TG
mice compared to WT mice fed standard chow or the HFD (Fig-
ure S8A). A similar trend was observed for Cd36. Both Fabp4
and Cd36 are targets of PPARg, an adipogenic-related protein
that was dramatically induced in WT HFD-fed mice (Fig-
ure S8B). Downstream target genes of PPARg, such as adipsin
and adiponectin, were also more induced in WT than in TG
mice fed HFD (Figure S8B). Affymetrix data comparing liver
gene expression in WT and TG HFD-fed mice also support
modulation of adipogenesis pathway (Figure S9). These results
suggest that fat intake is higher in livers of WT mice than in
TG mice.s 16, 2736–2748, September 6, 2016 2741
Figure 5. Rescue of PiT1 Expression or USP7 Knockdown in Pit1-KO MEFs Restores WT Phenotype
(A–C) Representative western blots of AKT phosphorylation in KO MEFs without (white bars) and with (hatched bars) expression of (A) wild-type PiT1 or (B)
transport-deficient PiT1 or (C) inhibition of Usp7 expression using a siRNA. The signal densities of protein bands shown in graphs were quantified using ImageJ
software and were normalized to GAPDH and total AKT protein band density. Data are means ± SEM of three to four independent experiments.
(D) (Left panel) Representative western blot of IRS1 ubiquitination in serum-starved, insulin-stimulated, MG132-treated MEFs. (Right panel) Whole lysate blot is
shown.
2742 Cell Reports 16, 2736–2748, September 6, 2016
Figure 6. Pit1 Hepatocyte KO Protects against HFD-Induced Obesity and Insulin Resistance
(A) Body weights of HFD-fed WT (gray bar) and TG mice (light gray bar) at 6 months of age.
(B) Liver weights of HFD-fed WT and TG mice normalized to body weights.
(C) Representative images of livers from HFD-fed WT (upper panel) and TG (lower panel) mice.
(D) Representative images of HFD-fed WT (upper) and TG (lower) liver tissue sections stained with H&E. The scale bar represents 1 mm.
(E) Hepatic triglyceride contents measured from HFD-fed WT (gray bar) and TG (light gray bar) mice.
(legend continued on next page)
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We next measured markers of fat synthesis. During feeding,
insulin and blood glucose stimulate expression of lipogenic
genes by regulating the liver transcription factors sterol regula-
tory element-binding protein-1c (SREBP-1c) and carbohydrates
responsive element-binding protein (ChREBP), respectively
(Dentin et al., 2004). Level of mRNAs encoding lipogenic enzyme
Scd1 was increased in livers of HFD-fed WT mice fed with HFD
but to a lesser extent in TGmice compared tomice fed chow diet
(Figure S8C). SREBP-1c and ChREBP levels were lower in TG
livers than WT livers under chow and HFD conditions (Figures
S8D and S8E). There was weaker expression of ACC1, FAS,
and SCD1 in the livers of TG mice fed HFD than in livers of
WT mice fed HFD (Figures S8D and S8E). Taken together, these
results suggest that lipogenesis is decreased in TG livers
(Figure S10).
Decreased lipogenic enzyme expression was confirmed
in vitro, using primary hepatocytes. There were similar levels of
expression of Chrebp and its target gene Lpk in WT and KO
hepatocytes (Figure S11A). Under high glucose concentrations
in the presence of insulin, glucose uptake (Figure S11B),
phosphate uptake (Figure S11C) necessary for oxidative phos-
phorylation, and ChREBP activation are identical in WT and KO
hepatocytes. Srebp1c and its target gene Gk levels were
decreased in KO hepatocytes compared to WT (Figure S11D),
suggesting that the lipogenic deficiency observed was caused
by impaired SREBP1 activation by insulin. Fasn, a target of
both ChREBP and SREBP1, was also expressed at lower levels
in KO hepatocytes.
Finally, we sought to determine whether oxidative pathways
were altered in TG mice. Cpt1a and Cpt2 mRNA expression
levels were not affected by PiT1 deficiency or by the HFD (Fig-
ure S8C). The HFD increased malonyl coenzyme A (CoA) decar-
boxylase (MCD) expression, but its expression remains lower in
TG mice than in WT mice (Figures S8D and S8E). In contrast,
ACC2 was increased in TGmice (Figure S8C). These results sug-
gest that b-oxidation decreased in TG livers relative to WT livers
(Figure S10), which is consistent with the decrease in hydroxybu-
tyrate levels observed in TG mice (Table 1) and Affymetrix data,
supporting differences in b-oxidation pathways (Figure S5).
Taken together, these data show that lack of PiT1 protects hepa-
tocytes against triglyceride accumulation through decreases in
fat intake and lipogenic gene expression probably due to a
defect in the lipogenic transcription factor SREBP1 activation.
Because low-grade inflammation of the liver is observed in
response to HFD, we analyzed expression of inflammation
markers. Levels of Mcp1 and F4/80 were higher in livers of WT
mice fed HFD compared to chow diet, as expected (Figure S12).
Tnfa expression also increased in response to HFD, although the(F) HFD-fedmice were fasted overnight and then injected intraperitoneally with 2 g
TG (dotted line) mice.
(G) HFD-fed mice were fasted overnight and then injected intraperitoneally with 1 U
and TG (dotted line) mice. Glycemia was normalized to basal glucose levels.
(H) HFD-fed mice were fasted overnight and then injected intraperitoneally with
and TG (dotted line) mice. For (F)–(H), data are means ± SEM of at least ten anima
**p < 0.01; ***p < 0.001).
(I) Representative western blot of liver proteins from HFD-fed mice after 5-min p
(J) Representative liver sections stained with PAS from WT (left) and TG (right) H
2744 Cell Reports 16, 2736–2748, September 6, 2016increase was not statistically significant (Figure S12A). Il6
expression was unchanged (data not shown). Levels of none of
these markers were significantly increased when TG mice were
fed HFD. Similarly, levels of Pai1, a marker of fibrosis, increased
in WT mice on the HFD, but not in TG mice (Figure S12A). Trans-
aminases and alkaline phosphatase, markers of liver injury, were
detected at lower concentrations in serum of TG mice than WT
mice (Figure S12B). These data are consistent with low levels
of triglyceride accumulation and little inflammation in livers of
TG mice fed a HFD.
Lack of PiT1 in Hepatocytes Protects against
HFD-Induced Insulin Resistance
The HFD increased fed-state glucose levels in WT mice, but not
in TG mice (Table 1). TG mice better tolerated the glucose chal-
lenge (Figure 6F), were more sensitive to insulin (Figure 6G), and
better tolerated pyruvate (Figure 6H) than did WT mice. Further,
HFD-fed TG mice had improved insulin signaling (Figure 6I),
correlated with higher glycogen storage in liver (Figure 6J). These
results show that KO hepatocytes maintained effective insulin
signaling despite a HFD, allowing protection against HFD-
induced insulin resistance.
DISCUSSION
In this study, we uncovered a role of PiT1 in metabolism, inde-
pendent of its phosphate transport function. We found that spe-
cific KO of Pit1 in hepatocytes unexpectedly protected mice
against HFD-induced obesity and diabetes. These mutant mice
displayed improved glucose tolerance, insulin sensitivity, insulin
signaling, and decreased hepatic lipogenesis compared to WT
mice. We identified USP7 as a PiT1 binding partner and showed
that, in the absence of PiT1, the complex of USP7 and IRS1 did
not dissociate upon insulin stimulation. This prevented IRS1
ubiquitination and its subsequent proteasomal degradation,
leading to a delayed insulin negative feedback loop and a pro-
longed signal.
Decreased adipose tissue deposition and inflammation in TG
mice seem to be direct consequences of insulin sensitivity,
whereas decreased steatosis appears to be linked to the lack
of PiT1. During feeding, insulin and blood glucose stimulate lipo-
genic genes by regulating the liver transcription factors SREBP-
1c and ChREBP, respectively (Dentin et al., 2004). In TG mice,
decreased ChREBP levels may be due to the lower glycemia
because it has been shown that high glucose concentrations in-
crease Chrebp mRNA levels in 3T3-L1 adipocytes (He et al.,
2004) and primary hepatocytes (Dentin et al., 2004). Srebp1
expression is induced by insulin (Fleischmann and Iynedjian,/kg body weight D-glucose. Blood glucose wasmeasured inWT (solid line) and
/kg body weight human insulin. Blood glucose wasmeasured inWT (solid line)
2 g/kg body weight pyruvate. Blood glucose was measured in WT (solid line)
ls per condition. Significant differences from WT mice are indicated (*p < 0.05;
ulse of insulin.
FD-fed mice. The scale bar represents 1 mm.
2000; Foretz et al., 1999), but TG mice, although more sensitive
to insulin than WT, have lower SREBP1c hepatic levels than WT
mice. Low levels of SREBP1 could explain the weak induction of
Pparg in HFD-fed TG mice. Indeed, ectopic expression of
SREBP1c increases PPARg expression and activity (Kim et al.,
1998), and this is both sufficient and necessary for the differen-
tiation of white fat adipocytes (Farmer, 2006; Tontonoz et al.,
1994). Conversely, PPARg has been reported to activate Lxra
gene expression (Chawla et al., 2001), which could in turn acti-
vate Srebp1c gene expression. Thus, induction of PPARg
expression could explain the high level of SREBP1c in WT
HFD-fed mice.
Our analysis of gene expression in livers of TG and WT mice
fed HFD showed a significant differential expression of genes
involved in the unfolded protein response pathway (Figure S9).
Thus, SREBP1/2 cleavage induced by endoplasmic reticulum
(ER) stress could explain higher lipogenic gene expression and
higher cholesterol levels in WT mice fed HFD when compared
to TG mice (Table 1). Indeed, accumulating evidence suggests
that ER stress response is critically involved in hepatic lipid
metabolism. The presence of ER stress is evident in livers of
HFD-induced obese mice (Ozcan et al., 2004, 2009) and rapidly
induces cleavage of the precursor form of SREBP1c and expres-
sion of its target genes independently of insulin (Kammoun et al.,
2009).
It has been reported that P53 was induced in adipocytes of
ob/ob mice in a fed state. Reporter gene analysis shows that
P53 overexpression suppresses expression of Srebp1c (Yahagi
et al., 2003). Such p53 induction has been described in ob/ob
mice and a transgenic mouse that overexpresses an active
form of SREBP-1c in the liver (Yahagi et al., 2004). In normal
cells, low P53 levels are maintained in absence of cellular
stress by constant ubiquitination and subsequent degradation
of P53 by the E2 ubiquitin enzyme MDM2. Stability of MDM2
requires deubiquitination by USP7 (Li et al., 2004a). Thus, we
speculate that the interaction we observed between PiT1 and
USP7 stabilizes P53, which represses Srebp1c expression in
TG liver and thus decreases lipogenesis and triglycerides
accumulation.
The insulin sensitivity in TG mice likely results from higher
levels of IR and from a delay in the negative feedback loop of in-
sulin signaling involving USP7. The deubiquitinating enzyme
USP7 associates with IRS1 in unstimulated conditions, stabiliz-
ing the protein. In response to insulin, the complex between
USP7 and IRS1 dissociates, allowing IRS1 ubiquitination and
subsequent degradation (Yoshihara et al., 2012). In addition to
activating tyrosine hyperphosphorylation by IR, IRS1 is also
phosphorylated on serine and threonine residues with both pos-
itive and negative effects on insulin sensitivity (Copps andWhite,
2012). Some of these phosphorylation events seem to be neces-
sary for IRS1 ubiquitination (Xu et al., 2012) and degradation
(Haruta et al., 2000; Ueno et al., 2005; Zhande et al., 2002). In
KO MEFs, we observed a decrease in global hyperphosphoryla-
tion of IRS1 compared to WT cells, and phosphorylation of
Ser302, Ser632, and Ser1097, which is dependent on mTOR/
S6K pathway (Tremblay et al., 2007) and/or PKCq (Li et al.,
2004b), was also impaired despite a similar activation of
mTOR/S6K pathway. We hypothesize that the alteration inIRS1 phosphorylation is the consequence of a phosphatase dys-
regulation instead of abnormal kinase activities; however, serine/
threonine phosphatases of IRS1 are currently unknown. Degra-
dation of IRS1 after prolonged insulin-mediated cell stimulation
has been reported in various cell lines (Haruta et al., 2000; Tzat-
sos and Kandror, 2006; Xu et al., 2008; Zhande et al., 2002).
Some reports suggest that the PI3K/AKT/mTOR pathway acti-
vates degradation of IRS1 (Haruta et al., 2000; Tzatsos and Kan-
dror, 2006; Xu et al., 2008), whereas other reports suggest that
activation of PI3K, but not mTOR, signaling is required for IRS1
degradation (Zhande et al., 2002). It is noteworthy that silencing
of Usp7 expression in KO MEFs restored IRS1 ubiquitination
without restoring serine/threonine phosphorylation of IRS1
(data not shown), showing that the phenotype of the TG mice
did not depend on mTOR/S6K-mediated phosphorylation. This
discrepancy could be attributed to the cell type used or to the di-
versity of the IRS1 ubiquitin ligases identified (Nakao et al., 2009;
Rui et al., 2002; Shi et al., 2011; Xu et al., 2008).
PTEN regulates insulin signaling at two levels. First, its lipid
phosphatase activity reverses PIP2 to PIP3 phosphorylation
that inhibits AKT phosphorylation. Second, its tyrosine phospha-
tase activity dephosphorylates and inactivates IRS1 (Shi et al.,
2014). Ubiquitination of PTEN appears to control its nuclear
localization and stability (Song et al., 2008; Trotman et al.,
2007) and, thus, its activity (Maccario et al., 2010). USP7 regu-
lates PTEN localization by modulation of ubiquitination (Song
et al., 2008); this suggests that USP7 could regulate dephos-
phorylation of IRS1 by PTEN as well as IRS1 stability.
Our evidence suggests that metabolic effects of PiT1 are inde-
pendent of its phosphate transport function. Expression of trans-
port-deficient mutant of PiT1 restored AKT signaling in KOMEFs.
Moreover, phosphate uptake was similar in WT and KO hepato-
cytes in the presence of high glucose concentration and insulin,
suggesting a compensatory mechanism that allows normal up-
take of phosphate. Depletion of intracellular phosphate would
involve AMPK phosphorylation; however, we did not observe
increased phosphorylation neither in vivo in livers of fasted TG
mice nor in vitro, in primary hepatocytes (data not shown).
Finally, depletion of intracellular phosphate would impair phos-
phorylation globally; however, we observed increased insulin
signaling with increased phosphorylation of IR and AKT in the
KO MEFs, arguing against a lack of phosphate availability in
these cells.
To summarize, specific KO of Pit1 in hepatocytes protected
mice against HFD-induced obesity and diabetes independently
of its phosphate transport function. Our findings suggest that
PiT1 has potential as a therapeutic target in the context of
metabolic syndrome, obesity, and diabetes. We found that
PiT1 regulates the interaction of USP7 with IRS1. USP7 has
been extensively studied in the context of carcinogenesis, and
an inhibitor is available (Colland et al., 2009). Additional analysis
of how PiT1 modulates activity of its binding partners may guide
development of more-effective modulators of fat deposition in
the liver.EXPERIMENTAL PROCEDURES
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Animals
Mice were maintained on standard rodent chow (Harlan Laboratories) or HFD
(60% calories from fat; ssniff) supplemented with fructose in drinking water
beginning at 5 weeks of age for 4 months. All animals used in this study
were male at 6 months of age. All procedures were approved by the Animal
Care and Use Committee of the University Paris Descartes.
Blood Chemistry and Metabolic Analyses
Samples were analyzed for glucose, triglycerides, non-esterified fatty acids,
glycerol, b-hydroxybutyrate (b-OH), HDLs, total cholesterol, and transami-
nases on an automatic analyzer (Olympus AU400). Insulin and glucagon con-
centrations were determined using the mouse endocrine LINCOplex Kit
(Millipore).
To evaluate glucose, insulin, and pyruvate tolerance, mice were fasted over-
night before experiments. Blood glucose levels were measured using a
portable glucometer (Roche). For insulin signaling analysis, mice were fasted
overnight and livers were harvested 5 min after insulin stimulation.
Histochemistry
Tissues were harvested and fixed with 4% formaldehyde in PBS and then
embedded in paraffin. Standard H&E or periodic acid-Schiff stainings were
performed on deparaffinized 5-mm sections.
Triglyceride Content Analysis
Livers of 6-month-old mice were frozen in liquid nitrogen and pulverized, and
50 mg of tissue were incubated in isopropanol overnight at 4C. Triglyceride
content was measured in supernatants using the colorimetric enzymatic test
for Triglycerides FS (Dyasis) according to the manufacturer’s instruction.
Indirect Calorimetry
Indirect calorimetry was performed using a computer-controlled, open-circuit
system (Columbus Oxymax Comprehensive Lab Animal Monitoring System).
Mice were individually tested during 24 hr in clear chambers (20 3 10 3
12.5 cm) with a plastic elevated wire floor after being acclimated over 2 days.
Cell Culture
MEFs were isolated as previously described (Beck et al., 2010), and HepG2
cells were maintained in DMEM supplemented with 10% fetal bovine serum
(FBS) at 5%CO2 in a humidified atmosphere. For plasmid and siRNA (Dharma-
con) transfections, cells were seeded 24 hr before the experiment in antibiotic-
freemedia. Cells were transfected using TransIT-mRNA transfection kit (Mirus)
or Lipofectamine 2000 (Life Technologies). Cells were starved overnight before
stimulation with serum-free medium containing 100 nM insulin and 10 mM
MG132 (Calbiochem).
Immunoprecipitation
Cells were cultured in serum-free medium overnight and treated with serum-
free medium containing 100 nM insulin and 10 mM MG132 (Calbiochem).
Western Blotting
Tissues or cells were incubated for 30 min in ice-cold lysis buffer (150 mM
NaCl, 10 mM Tris HCl, 5 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% deoxycho-
late, 1 mM Na3VO4, 1 mM NaF, 5 mM sodium pyrophosphate, and a protease
inhibitor cocktail). After centrifugation at 20,000 g for 15 min, supernatants
were boiled in 13 SDS loading buffer prior to SDS-PAGE. Proteins were
transferred to polyvinylidene fluoride (PVDF) membrane and blocked with
5% milk/TBST (10 mM Tris [pH 7.5], 150 mM NaCl, and 0.15% Tween 20)
for 1 hr. Blots were probed with specific primary antibodies in 5% BSA over-
night at 4C followed by horseradish peroxidase (HRP)-conjugated secondary
antibodies and subsequent enhanced chemiluminescence (ECL) detection re-
agent (Thermo Fisher Scientific).
Gene Expression Analysis
Total RNAwas isolated from cells usingNucleoSpin RNA II columns (Macherey
Nagel) and from adipose tissues using the RNeasy mini kit (QIAGEN). RT-PCR
amplifications were performed using M-MLV (Invitrogen) according to manu-
facturer’s instruction. Real-time PCR was performed using SyBr green chem-2746 Cell Reports 16, 2736–2748, September 6, 2016istry (Thermo Fisher Scientific). The pinin gene was used as the reference gene
(Ouyang and Sugrue, 1996), and expression differences were calculated as
described previously (Livak and Schmittgen, 2001). For total liver tissues,
RT-PCR amplifications were performed using High-Capacity RNA-to-cDNA
kit (Life Technologies) according to manufacturer’s instruction. Real-time
PCR was performed using Taqman Low Density Array cards (Life Technolo-
gies) on a ViiA 7 real-time PCR system (Life Technologies), and the b2 micro-
globulin gene was used as the reference gene.
Microarray Experiments
Microarray experiments were performed on Affymetrix Mouse Genome 430
2.0 GeneChips.
Statistical Analysis
Results are presented as means ± SEM. Statistical analyses were performed
using the Student’s t test, the Welch t test, when SDs were different, or the
non-parametric Mann-Whitney U test.
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